Tóm tắt
Background: Sepsis remains a leading cause of hospital mortality worldwide, placing significant pressure on healthcare systems. Therefore, investigating severe prognostic factors in patients with sepsis is crucial for improving prevention and treatment outcomes.
Objective: To describe clinical and laboratory characteristics and evaluate severe prognostic factors for severity and mortality in patients with sepsis.
Methods: A cross-sectional descriptive study was conducted on 107 patients admitted to the Intensive Care Unit (ICU) at Hue Central Hospital from September 2024 to November 2024. Data were collected from medical records and patient/relative interviews. Statistical analysis included Receiver Operating Characteristic (ROC) curves to determine the Area Under the Curve (AUC) for prognostic factors.
Results: The mean age was 64.44 ± 15.75 years. The incidence of septic shock was 60.7% (65/107), and the mortality rate was 48.6% (52/107). Regarding prognostic factors for severity: Procalcitonin (PCT) at a cutoff of 7.012 ng/mL had a sensitivity of 89.2% and specificity of 78.2%; Lactate at a cutoff of 2.395 mmol/L had a sensitivity of 93.8% and specificity of 78.6%. Regarding mortality prediction: The SOFA and APACHE II scores showed significant predictive value, with SOFA (AUC 0.907) demonstrating high specificity (98.2%) for mortality risk.
Conclusion: PCT and blood lactate levels are valuable for predicting severe outcomes in sepsis patients. Furthermore, the SOFA and APACHE II scoring systems are useful in predicting progression to septic shock and mortality in the study population.
| Đã xuất bản | 03-01-2026 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Tập 15 Số 6 (2025) | |
| Phân mục | Nghiên cứu | |
| DOI | 10.34071/jmp.2025.6.590 | |
| Từ khóa | Hep-G2, Gymnosporia chevalieri, anti-inflammatory, Total triterpenoid, A549 |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2026 Tạp chí Y Dược Huế
Plants of the World Online [Internet]. [cited 2024 Mar 28]. Gymnosporia (Wight & Arn.) Hook.f. | Plants of the World Online | Kew Science.
Kulshreshtha DK. Three new oxygenated triterpenoids of the lupane series from Gymnosporia wallichiana. Phytochemistry. 1977;16(11):1783–1785.
Joshi KC, Bansal RK, Patni R. Chemical constituents of Gymnosporia montana Euonymus pendulus. Planta Medica. 2009;34:211–214.
Wijeratne DBT, Kumar V, Uvais M, Sultanbawa S, Balasubramaniam S. Triterpenes from Gymnosporia emarginata. Phytochemistry. 1982;21(9):2422–2323.
Ochieng CO, Opiyo SA, Mureka EW, Ishola IO. Cyclooxygenase inhibitory compounds from Gymnosporia heterophylla aerial parts. Fitoterapia. 2017;119:168–174.
Bhavita D, Lakshmi B, Maitreyl Z. An overview on ethanomedicinal plant Gymnosporia montana of Celestraceae family. Int J Pharmacogn Chinese Med. 2017; 1(1):000106.
Ndako M, Jigam AA, Kabiru AY, Umar SI, Lawal B. Polar extracts from Gymnosporia senegalensis (syn. Maytenus senegalensis) root bark, its effects on nociception, edema, and malarial infection. Phytomedicine Plus. 2021;1(4):100113.
Sosa S, Morelli CF, Tubaro A, Cairoli P, Speranza G, Manitto P. Anti-inflammatory activity of Maytenus senegalensis root extracts and of maytenoic acid. Phytomedicine. 2007;14(2):109–114.
Lee KH, Nozaki H, Hall IH, Kasai R, Hirayama T, Suzuki H, et al. Antitumor Agents 60. Maytansine, an antileukemic principle from Maytenus diversifolia. J Nat Prod. 1982;45(4):509–510.
Cabanillas F, Bodey GP, Burgess MA, Freireich EJ. Results of a phase II study of maytansine in patients with breast carcinoma and melanoma. Cancer Treat Rep. 1979;63(3):507–509.
Geran RI, Greenberg NH, MacDonald MM, Schumacher A, Abbott BJ. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep. 1972: 3(2).
Kuo YH, Chen CH, Kuo LM, King ML, Wu TS, Haruna M, et al. Antitumor agents, 112. Emarginatine B, a novel potent cytotoxic sesquiterpene pyridine alkaloid from Maytenus emarginata. J Nat Prod, 1990; 53(2):422-428.
Anywar G, Kakudidi E, Byamukama R, Mukonzo J, Schubert A, Oryem-Origa H, et al. A review of the toxicity and phytochemistry of medicinal plant species used by herbalists in treating people living with HIV/AIDS in Uganda. Front Pharmacol. 2021;12:615147.
Sandeep, Ghosh S. Chapter 12 - Triterpenoids: structural diversity, biosynthetic pathway, and bioactivity - Studies in Natural Products Chemistry. Elsevier; 2020;411–461.
Pham HH. An illustrated flora of Vietnam [in Vietnamese], 2nd ed. Tre Publishing House, Ho Chi Minh City, Viet Nam; 2000;151–153.
Ho DV, Kodama T, Le HTB, Phan KV, Do TT, Bui TH, et al. A new polyoxygenated cyclohexene and a new megastigmane glycoside from Uvaria grandiflora. Bioorg Med Chem. Lett. 2015;25(16):3246–3250.
Ho VD, Hoang TNH, Vo QH, Phan VK, Le TA, Pham VT, et al. Cycloartane-type triterpene glycosides anopanins A-C with monoacyldigalactosylglycerols from Anodendron paniculatum. Phytochemistry. 2017;144:113–118.
Nguyen KV, Ho DV, Nguyen HM, Do TT, Phan KV, Morita H, et al. Chiro-inositol derivatives from Chisocheton paniculatus showing inhibition of nitric oxide production. J Nat Prod. 2020;83(4):1201–1206.
Antony A, Farid M. Effect of temperatures on polyphenols during extraction. Applied Sciences. 2022;12(4):2107.
Ochieng CO, Opiyo SA, Mureka EW, Ishola IO. Cyclooxygenase inhibitory compounds from Gymnosporia heterophylla aerial parts. Fitoterapia. 2017;119:168–74.
Tran DT, Nguyen PH, Tran MH, Nguyen PD, Ngu TN, Pham THT, et al. Chemical constituents of Gymnosporia stylosa and their anti-inflammatory activity. Rec Nat Prod. 2020;15(1):59–64.
Alate AD, Khandalekar DD, Amonkar AJ, Adwankar MK, Sahasrabudhe MB. A new anti-cancer principle isolated from Gymnosporia rothiana Laws, and its use in attaining cures in L1210 leukaemia in combination with “S” phase sensitive drugs. Biomedicine. 1978;28(5):270–273.
Lee KH, Kuo YH, Chen CH, Yang Kuo LM, King ML, Wu TS, et al. Structure and stereochemistry of Emargiatine-A, a novel cytotoxic sesquiterpene pyridine alkaloid from Maytenus emarginata: X-ray crystal steructure of Emarginatine-A monohydrate. Heterocycles. 1989;29(8):1465.
Kuo YH, King ML, Chen CF, Chen HY, Chen CH, Chen K, et al. Two new macrolide sesquiterpene pyridine alkaloids from Maytenus emarginata: Emarginatine G and the cytotoxic emarginatine F. J Nat Prod. 1994;57(2):263–9.
Deng JZ, Newman DJ, Hecht SM. Use of COMPARE analysis to discover functional analogues of bleomycin. J Nat Prod. 2000;63(9):1269–72.
Joshi KC, Singh P, Singhi CL. Triterpene quinone-methides from Gymnosporia montana. Planta Med. 1981;43(1):89–91.
Deeb D, Gao X, Liu YB, Pindolia K, Gautam SC. Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2. Int J Oncol. 2014;44(5):1707–1715.
Da Silva G, Martinho A, Soengas RG, Duarte AP, Serrano R, Gomes ET, et al. A new spermidine macrocyclic alkaloid isolated from Gymnosporia arenicola leaf. Fitoterapia. 2015;106:7–11.
Tatsimo JSN, Toume K, Nagata T, Havyarimana L, Fujii T, Komatsu K. Monoglycerol ester, galloylglucoside and phenolic derivatives from Gymnosporia senegalensis leaves. Biochemical Systematics and Ecology. 2019;83:33–8.
Nghia DTA, Hanh HTN, Anh LT, Van LTH, Hung VQ, Duc HV, et al. Isolation and structural determination of pentacyclic triterpenoids from the leaves of Gymnosporia chevalieri Tard. Hue J Med Pharm. 2025;06(14):134.
Safayhi H, Sailer ER. Anti-inflammatory actions of pentacyclic triterpenes. Planta Med 1997; 63(6): 487-493.
Ghante MH, Jamkhande PG. Role of pentacyclic triterpenoids in chemoprevention and anticancer treatment: an overview on targets and underling mechanisms. J Pharmacopuncture. 2019;22(2):55-67.